Although further in vivo research is eminent, our findings deepen the understanding of the molecular interplay of ATIII, HSPGs, and SCV2, hence facilitating the development of novel COVID-19 treatment strategies and safer COVID-19 immunization protocols. The gene discussed is SERPINC1; the disease is COVID-19.